We are live on
!
Find out more
CAM
ClariVest Asset Management Portfolio holdings
AUM
$980M
1-Year Est. Return
60.89%
This Fund
S&P 500
This Quarter
Est. Return
+16.16%
1 Year Est. Return
+60.89%
3 Year Est. Return
+106.43%
5 Year Est. Return
+337.88%
10 Year Est. Return
+1,091.18%
AUM
$1.8B
AUM Growth
-$33.2M
(-1.8%)
Cap. Flow
-$263M
Cap. Flow
% of AUM
-14.6%
Top 10 Holdings %
Top 10 Hldgs %
39.15%
Holding
968
New
154
Increased
143
Reduced
305
Closed
101
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lennox International
LII
|
+$8.48M |
| 2 |
Leidos
LDOS
|
+$7.61M |
| 3 |
GE Aerospace
GE
|
+$7.52M |
| 4 |
AT&T
T
|
+$6.41M |
| 5 |
Nutanix
NTNX
|
+$5.94M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$28M |
| 2 |
Apple
AAPL
|
+$27.6M |
| 3 |
Microchip Technology
MCHP
|
+$13.9M |
| 4 |
Intuitive Surgical
ISRG
|
+$13.9M |
| 5 |
NVIDIA
NVDA
|
+$13.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 42.57% |
| 2 | Healthcare | 13.29% |
| 3 | Consumer Discretionary | 13.19% |
| 4 | Communication Services | 10.36% |
| 5 | Industrials | 8.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
351
TG Therapeutics
TGTX
$7.62B
| $561K | 0.03% |
32,838
-42,635
| -56% | -$496K |
|
|
CRON
352
Cronos Group
CRON
$1.14B
| $554K | 0.03% |
265,161
+6,306
| +2% | +$12.2K |
|
353
Information Services Group
III
$251M
| $546K | 0.03% |
115,846
-36,290
| -24% | -$159K |
|
|
SFIX
354
Stitch Fix
SFIX
$560M
| $542K | 0.03% |
151,834
+3,634
| +2% | +$12.8K |
|
355
McEwen Inc
MUX
$1.18B
| $536K | 0.03% |
+74,397
| New | +$538K |
|
356
NeoGenomics
NEO
$2.13B
| $534K | 0.03% |
32,992
-5,800
| -15% | -$94.9K |
|
357
Voyager Therapeutics
VYGR
$201M
| $530K | 0.03% |
62,848
+13,548
| +27% | +$98.3K |
|
358
Marqeta
MQ
$1.66B
| $527K | 0.03% |
18,876
-3,375
| -15% | -$80.8K |
|
359
Blend Labs
BLND
$386M
| $523K | 0.03% |
+204,913
| New | +$309K |
|
360
UMB Financial
UMBF
$11.1B
| $505K | 0.03% |
+6,049
| New | +$425K |
|
361
Helmerich & Payne
HP
$3.71B
| $504K | 0.03% |
13,903
-2,500
| -15% | -$96.7K |
|
362
Digi International
DGII
$3.1B
| $503K | 0.03% |
19,329
+465
| +2% | +$11.5K |
|
363
QuinStreet
QNST
$1.21B
| $490K | 0.03% |
+38,200
| New | +$430K |
|
364
Shake Shack
SHAK
$2.87B
| $445K | 0.02% |
6,010
-1,000
| -14% | -$61.3K |
|
365
Ultralife
ULBI
$106M
| $441K | 0.02% |
64,672
+1,572
| +2% | +$12.9K |
|
366
EnerSys
ENS
$6.99B
| $432K | 0.02% |
4,280
-30,958
| -88% | -$2.85M |
|
|
ARIS
367
DELISTED
Aris Water Solutions
ARIS
| $402K | 0.02% |
+47,900
| New | +$412K |
|
368
Oceaneering
OII
$4.77B
| $392K | 0.02% |
18,413
-3,200
| -15% | -$70.9K |
|
369
Heritage Insurance Holdings
HRTG
$991M
| $390K | 0.02% |
+59,802
| New | +$412K |
|
370
Weatherford International
WFRD
$6.22B
| $369K | 0.02% |
3,773
-700
| -16% | -$65.1K |
|
|
HCP
371
DELISTED
HashiCorp, Inc. Class A Common Stock
HCP
| $365K | 0.02% |
15,440
-2,700
| -15% | -$58.5K |
|
372
BlackLine
BL
$1.72B
| $351K | 0.02% |
+5,626
| New | +$318K |
|
373
Beam Therapeutics
BEAM
$2.84B
| $349K | 0.02% |
12,831
-2,319
| -15% | -$57.6K |
|
374
Hippo Holdings
HIPO
$861M
| $346K | 0.02% |
37,944
+891
| +2% | +$7.39K |
|
375
Tenable Holdings
TENB
$4.01B
| $338K | 0.02% |
7,346
-1,300
| -15% | -$54.7K |
|
Similar funds
GCAC
D
PP
FTIS
AIA
SEC
AFG
ECM
ClariVest Asset Management's Q4 2023 Portfolio in Review
As of Q4 2023, ClariVest Asset Management held 968 positions worth $1.8B, down 1.8% from $1.84B the previous quarter. Its ten largest holdings account for 39% of the portfolio.
ClariVest Asset Management withdrew a net $263M in Q4 2023, closing 101 positions and reducing 305 holdings. Its most notable exit was Belden, an estimated $4.08M position sold in full.
By sector, the portfolio is most concentrated in Technology at 43% of assets, down from 43% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, ClariVest Asset Management opened a new position in Lennox International worth $9.52M.
- ClariVest Asset Management's largest Q4 2023 buy was Lennox International: 21,263 shares worth $9.52M.
- ClariVest Asset Management added most to Leidos in Q4 2023, an estimated $7.61M increase.
- ClariVest Asset Management's biggest Q4 2023 reduction was Microsoft, cutting an estimated $28M.
- ClariVest Asset Management fully exited Belden in Q4 2023, selling an estimated $4.08M.
- ClariVest Asset Management's ten largest holdings make up 39% of its $1.8B portfolio in Q4 2023.
- ClariVest Asset Management opened 154 new positions and closed 101 in Q4 2023.
- ClariVest Asset Management's portfolio value fell 1.8% quarter-over-quarter to $1.8B.
Based on ClariVest Asset Management's 13F filing for Q4 2023, filed 13 Feb 2024.